The development and validation of the Treatment of Autoimmune Bullous Disease Quality of Life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease

Development of a Quality-of-Life Instrument for Autoimmune Bullous Disease

(2013) Deshan F. Sebaratnam et al.   JAMA Dermatology

Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts

(2011) Dedee F. Murrell et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: Facts and controversies

(2010) A. Lo Schiavo et al.   CLINICS IN DERMATOLOGY

Development and validation of a questionnaire measuring quality of life in primary caregivers of children with atopic dermatitis (QPCAD)

(2009) K. Kondo-Endo et al.   BRITISH JOURNAL OF DERMATOLOGY

Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives

(2009) Jacqueline A. Guidry et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

The use of questionnaires for measuring patient-reported side effects of drugs: its importance and methodological challenges

(2008) Juliet M. Foster PhD et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Measuring symptom experience of side-effects of immunosuppressive drugs: the Modified Transplant Symptom Occurrence and Distress Scale

(2008) Fabienne Dobbels et al.   TRANSPLANT INTERNATIONAL